Open AccessDay at the Races: Comparing BioFire FilmArray Blood Culture ID Panels With Verigene Blood Culture Panel in Gram-Negative Bloodstream Infections Using DOOR-MAT Analysis
Author(s) -
Kimberly C Claeys,
Kathryn Schlaffer,
Richard T. Smith,
Stephanie Hitchcock,
Yunyun Jiang,
Scott Evans,
J. Kristie Johnson,
Surbhi Leekha
Publication year - 2021
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab262
Subject(s) - medicine , blood culture , gram , antimicrobial , bloodstream infection , ranking (information retrieval) , test (biology) , microbiology and biotechnology , bacteria , artificial intelligence , antibiotics , computer science , biology , ecology , genetics
Three rapid diagnostic test panels (Verigene BC-GN, BioFire BCID, and BCID 2 [RUO]) were compared using the Desirability of Outcome Ranking Management of Antimicrobial Therapy (DOOR-MAT) to evaluate potential downstream antimicrobial prescribing decisions resulting from the panels’ different organism and resistance detection. BioFire BCID 2 (RUO) had the best mean DOOR-MAT scores.